762543

    500009

    AMBALALSA

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    Ambalal Sarabhai Ent L Share Price Today

    AMBALAL SARABHAI ENT L is currently trading at ₹30.83, down by ₹0.05 from the previous close. The stock touched an intraday high of ₹31.29 and a low of ₹30.78 during the latest trading session. Over the past one year, AMBALAL SARABHAI ENT L has delivered a return of 0.0%, while the stock has declined 4.39% in the last one month.

    Ambalal Sarabhai Ent L performance

    Today’s low Today’s high
    ₹ 30.78 ₹ 31.29
    ₹ 31.20
    52 week low 52 week high
    ₹ 30.30 ₹ 38.50
    ₹ 31.20
    Open Price ₹ 31.13
    Prev. Close ₹ 30.89
    Volume (Shares) 8696.00
    Total traded value ₹ 2.71
    Upper Circuit ₹ 37.06
    Lower Circuit ₹ 24.72
    info

    Investment Returns

    Over 1 Month -4.39% Over 3 Months -4.80% Over 6 Months 0.00% Over 1 Year 0.00%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    Ambalal Sarabhai Ent L fundamentals


    • Market cap (Cr) 239.10
    • P/E Ratio (TTM) 21.65
    • Beta 14.56
    • Book Value / share 7.76
    • Return on equity 7.67%
    • EPS (TTM) 1.43
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) 2.65
    info icon alternate text
    • Market cap (Cr) 239.90
    • P/E Ratio (TTM) 21.65
    • Beta 0.63
    • Book Value / share 7.76
    • Return on equity 7.67%
    • EPS (TTM) 1.43
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) 2.65
    info icon alternate text

    Ambalal Sarabhai Ent L Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 1.52
    Operating Expense 3.07
    Net Profit 2.65
    Net Profit Margin (%) 174.34
    Earnings Per Share (EPS) 0.35
    EBITDA 1.80
    Effective Tax Rate (%) -64.59
    Particulars DEC 2025 (Values in Cr)
    Revenue 0.00
    Operating Expense 1.06
    Net Profit 1.84
    Net Profit Margin (%) 0.00
    Earnings Per Share (EPS) 0.24
    EBITDA 1.94
    Effective Tax Rate (%) -0.54
    Particulars SEP 2025 (Values in Cr)
    Revenue 0.79
    Operating Expense 2.53
    Net Profit -0.38
    Net Profit Margin (%) -48.10
    Earnings Per Share (EPS) -0.05
    EBITDA -0.27
    Effective Tax Rate (%) 0.00
    Particulars JUN 2025 (Values in Cr)
    Revenue 1.64
    Operating Expense 2.90
    Net Profit 6.88
    Net Profit Margin (%) 419.51
    Earnings Per Share (EPS) 0.90
    EBITDA 6.97
    Effective Tax Rate (%) 0.00
    Particulars MAR 2025 (Values in Cr)
    Revenue 1.73
    Operating Expense 3.50
    Net Profit -4.96
    Net Profit Margin (%) -286.70
    Earnings Per Share (EPS) -0.64
    EBITDA -4.91
    Effective Tax Rate (%) 0.40
    Particulars MAR 2026 (Values in Cr)
    Revenue 3.94
    Operating Expense 9.56
    Net Profit 10.99
    Net Profit Margin (%) 278.93
    Earnings Per Share (EPS) 1.43
    EBITDA 10.44
    Effective Tax Rate (%) -10.45
    Particulars MAR 2025 (Values in Cr)
    Revenue 4.04
    Operating Expense 11.81
    Net Profit 8.24
    Net Profit Margin (%) 203.96
    Earnings Per Share (EPS) 1.08
    EBITDA 8.52
    Effective Tax Rate (%) -1.98
    Particulars MAR 2024 (Values in Cr)
    Revenue 3.81
    Operating Expense 10.87
    Net Profit 2.58
    Net Profit Margin (%) 67.71
    Earnings Per Share (EPS) 0.34
    EBITDA 1.12
    Effective Tax Rate (%) -218.51
    Particulars MAR 2023 (Values in Cr)
    Revenue 3.71
    Operating Expense 9.12
    Net Profit 4.11
    Net Profit Margin (%) 110.78
    Earnings Per Share (EPS) 0.54
    EBITDA 4.60
    Effective Tax Rate (%) 5.29
    Particulars MAR 2022 (Values in Cr)
    Revenue 0.13
    Operating Expense 6.14
    Net Profit 2.96
    Net Profit Margin (%) 2276.92
    Earnings Per Share (EPS) 0.39
    EBITDA 3.89
    Effective Tax Rate (%) 14.49
    Particulars MAR 2026 (Values in Cr)
    Book Value / Share 20.66
    ROE % 11.82
    ROCE % 11.19
    Total Debt to Total Equity 0.36
    EBITDA Margin 13.30
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 18.27
    ROE % 6.95
    ROCE % 8.87
    Total Debt to Total Equity 0.35
    EBITDA Margin 10.72
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 17.80
    ROE % 3.98
    ROCE % 6.73
    Total Debt to Total Equity 0.34
    EBITDA Margin 9.40
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 17.08
    ROE % 8.01
    ROCE % 9.92
    Total Debt to Total Equity 0.29
    EBITDA Margin 12.12
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 15.64
    ROE % 24.23
    ROCE % 24.22
    Total Debt to Total Equity 0.28
    EBITDA Margin 22.45
    Particulars MAR 2026 (Values in Cr)
    Book Value / Share 7.76
    ROE % 7.67
    ROCE % 6.77
    Total Debt to Total Equity 0.17
    EBITDA Margin 265.23
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 6.33
    ROE % 2.11
    ROCE % 2.10
    Total Debt to Total Equity 0.20
    EBITDA Margin 81.68
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 5.26
    ROE % 1.80
    ROCE % 1.92
    Total Debt to Total Equity 0.28
    EBITDA Margin 81.10
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 4.94
    ROE % 3.35
    ROCE % 3.35
    Total Debt to Total Equity 0.30
    EBITDA Margin 143.13
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 4.40
    ROE % 3.89
    ROCE % 4.31
    Total Debt to Total Equity 0.32
    EBITDA Margin 3407.69
    Particulars MAR 2026 (Values in Cr)
    Cash & Short Term Investments 19.40
    Total Assets 281.12
    Total Liabilities 281.12
    Total Equity 158.36
    Share Outstanding 7
    Price to Book Ratio 3.13
    Return on Assets (%) 6.33
    Return on Capital (%) 8.48
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 11.51
    Total Assets 271.67
    Total Liabilities 271.67
    Total Equity 139.97
    Share Outstanding 7
    Price to Book Ratio 5.54
    Return on Assets (%) 1.81
    Return on Capital (%) 2.62
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 32.90
    Total Assets 249.52
    Total Liabilities 249.52
    Total Equity 136.42
    Share Outstanding 7
    Price to Book Ratio 8.65
    Return on Assets (%) 2.27
    Return on Capital (%) 3.13
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 28.08
    Total Assets 245.74
    Total Liabilities 245.74
    Total Equity 130.92
    Share Outstanding 7
    Price to Book Ratio 4.15
    Return on Assets (%) 4.65
    Return on Capital (%) 6.57
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 28.25
    Total Assets 230.50
    Total Liabilities 230.50
    Total Equity 119.85
    Share Outstanding 7
    Price to Book Ratio 7.93
    Return on Assets (%) 20.48
    Return on Capital (%) 32.46
    Particulars MAR 2026 (Values in Cr)
    Cash & Short Term Investments 3.68
    Total Assets 85.79
    Total Liabilities 85.79
    Total Equity 59.48
    Share Outstanding 7
    Price to Book Ratio 3.13
    Return on Assets (%) 12.81
    Return on Capital (%) 15.59
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 3.28
    Total Assets 82.91
    Total Liabilities 82.91
    Total Equity 48.49
    Share Outstanding 7
    Price to Book Ratio 5.54
    Return on Assets (%) 9.93
    Return on Capital (%) 14.68
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 3.01
    Total Assets 81.28
    Total Liabilities 81.28
    Total Equity 40.29
    Share Outstanding 7
    Price to Book Ratio 8.65
    Return on Assets (%) 3.17
    Return on Capital (%) 5.13
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 3.45
    Total Assets 79.74
    Total Liabilities 79.74
    Total Equity 37.84
    Share Outstanding 7
    Price to Book Ratio 4.15
    Return on Assets (%) 5.15
    Return on Capital (%) 8.33
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 5.08
    Total Assets 82.98
    Total Liabilities 82.98
    Total Equity 33.70
    Share Outstanding 7
    Price to Book Ratio 7.93
    Return on Assets (%) 3.56
    Return on Capital (%) 6.8
    Particulars MAR 2026 (Values in Cr)
    Net Income 18.50
    Cash from Operations 12.91
    Cash from Investing -10.25
    Cash from Financing -1.84
    Net change in Cash 1.29
    Free Cash Flow 17.16
    Particulars MAR 2025 (Values in Cr)
    Net Income 4.83
    Cash from Operations -14.40
    Cash from Investing 13.26
    Cash from Financing -1.51
    Net change in Cash -5.88
    Free Cash Flow -11.68
    Particulars MAR 2024 (Values in Cr)
    Net Income 6.65
    Cash from Operations 12.88
    Cash from Investing -5.29
    Cash from Financing -2.94
    Net change in Cash 0.64
    Free Cash Flow 15.79
    Particulars MAR 2023 (Values in Cr)
    Net Income 15.17
    Cash from Operations 10.14
    Cash from Investing -16.78
    Cash from Financing 9.08
    Net change in Cash -1.97
    Free Cash Flow 30.80
    Particulars MAR 2022 (Values in Cr)
    Net Income 54.19
    Cash from Operations 15.02
    Cash from Investing 5.07
    Cash from Financing -19.18
    Net change in Cash -2.63
    Free Cash Flow 29.35
    Particulars MAR 2026 (Values in Cr)
    Net Income 9.95
    Cash from Operations -3.10
    Cash from Investing -3.02
    Cash from Financing 3.39
    Net change in Cash 0.11
    Free Cash Flow -3.09
    Particulars MAR 2025 (Values in Cr)
    Net Income 8.07
    Cash from Operations -3.43
    Cash from Investing 6.34
    Cash from Financing -2.30
    Net change in Cash -0.04
    Free Cash Flow -3.33
    Particulars MAR 2024 (Values in Cr)
    Net Income 0.81
    Cash from Operations -3.13
    Cash from Investing 3.47
    Cash from Financing 0.29
    Net change in Cash -0.04
    Free Cash Flow -3.04
    Particulars MAR 2023 (Values in Cr)
    Net Income 4.33
    Cash from Operations 2.30
    Cash from Investing 0.60
    Cash from Financing -3.76
    Net change in Cash -1.63
    Free Cash Flow 2.34
    Particulars MAR 2022 (Values in Cr)
    Net Income 3.45
    Cash from Operations -7.16
    Cash from Investing 20.77
    Cash from Financing -16.45
    Net change in Cash -3.47
    Free Cash Flow -7.13
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    BLISS GVS PHARMA LTD 482.50 38.79 4.28 5117.21 118.35 552.90
    CIPLA LTD. 1418.40 30.10 3.32 114584.78 1165.55 1672.20
    FERMENTA BIOTECH LIMITED 431.50 19.03 3.12 1269.95 256.40 480.00
    GLAXOSMITHKLINE PHARMACEUTICAL 2455.05 43.22 18.34 41590.03 2088.00 3217.10
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMRUTANJAN HEALTH CARE LTD. 537.90 24.11 4.20 1555.10 490.00 789.95
    ASTRAZENECA PHARMA IND LT 8025.95 104.82 22.98 20064.88 7630.00 9850.00
    BLISS GVS PHARMA LTD 482.50 52.16 4.42 5117.21 118.35 552.90
    ABBOTT INDIA LIMITED 28013.60 38.36 12.46 59528.90 25164.00 35280.00

    Ambalal Sarabhai Ent L shareholding pattern

    Holding
    68.63%
    31.35%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    Ambalal Sarabhai Ent L Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    31.20 1.00 redarrow
    red-green-graph indicator
    14 Bearish
    2 Bullish
    • 5 Days 31.20
    • 26 Days 31.90
    • 10 Days 31.40
    • 50 Days 32.30
    • 12 Days 31.50
    • 100 Days 32.50
    • 20 Days 31.70
    • 200 Days 32.50
    31.31 PIVOT
    First Support 30.82 First Resistance 31.71 Second Support 30.42 Second Resistance 32.20 Third Support 29.93 Third Resistance 32.60
    RSI 41.50 ADX 15.83 MACD -0.44 Williams % R -90.60 Commodity Channel Index (CCI) -159.32
    Date 2026-07-17 Week 22527.00 Same Day 14933.00 Month 32144.00
    1 Year 14.56 3 Year 13.95
    Over 1 Month
    -4.39% down
    Over 1 Year
    0.00% down
    Over 3 Months
    -4.80% down
    Over 3 Years
    0.00% down
    Over 6 Months
    0.00% down
    Over 5 Years
    0.00% down

    Ambalal Sarabhai Ent L Corporate Actions

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Ambalal Sarabhai Enterprises Ltd?

    Answer Field

    Ambalal Sarabhai Enterprises Ltd share price is for NSE ₹ 30.83 & for BSE ₹ 31.00 as on Jul 20 2026 03:29 PM.

    What is the Market Cap of Ambalal Sarabhai Enterprises Ltd Share?

    Answer Field

    The market cap of Ambalal Sarabhai Enterprises Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jul 20 2026 03:29 PM.

    What is the 52 Week High and Low of Ambalal Sarabhai Enterprises Ltd?

    Answer Field

    The 52 Week High and Low of Ambalal Sarabhai Enterprises Ltd for NSE is ₹ 38.50 and ₹ 30.30 and for BSE is ₹ 38.85 and ₹ 23.12.

    What is 1 year return for Ambalal Sarabhai Enterprises Ltd?

    Answer Field

    The 1 year returns on the stock has been 0.00%.

    What is the P/E Ratio of Ambalal Sarabhai Enterprises Ltd Share?

    Answer Field

    As on Jul 20 2026 03:29 PM the price-to-earnings (PE) ratio for Ambalal Sarabhai Enterprises Ltd share is 21.65.

    What is the PB ratio of Ambalal Sarabhai Enterprises Ltd Share?

    Answer Field

    As on Jul 20 2026 03:29 PM, the price-to-book (PB) ratio for Ambalal Sarabhai Enterprises Ltd share is 7.76.

    How to Buy Ambalal Sarabhai Enterprises Ltd Share?

    Answer Field

    You can trade in Ambalal Sarabhai Enterprises Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Ambalal Sarabhai Enterprises Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Ambalal Sarabhai Enterprises Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Ambalal Sarabhai Enterprises Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |